Hepatitis C among hemodialysis patients: Impact of strict adherence to universal precautions

Hepatitis Monthly

Volumn 7, Issue 4, 2007, Pages 245-246

  Nemati, Eghlim ^a   Taheri, Saeed ^a   Einollahi, Behzad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; BLOOD TRANSFUSION; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; POLYMERASE CHAIN REACTION; UNIVERSAL PRECAUTION; VIRUS TRANSMISSION;

EID: 77955372594     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M. Hepatitis C among hemodialysis patients: a review on epidemiologic, diagnostic, and therapeutic features. Hep Mon 2007; 7: 153-62.
2. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton) 2003; 8: 256-60.
3. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, et al. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998; 36: 1711-5.
4. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47: 1-39.
5. Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 1998; 53: 1022-5.